pipette
ENEnglish

CATFISHR: integration of transcriptome and inferred CNV profiles for comprehensive malignant cell identification

P. Shukla, M. Mannino, M. Hofer, E. R. Lattmann, V. Haunerdinger, P. Turko, M. P. Levesque

PreprintUso en el mundo real

En palabras de los autores

Malignant cell identification in single-cell RNA sequencing (scRNA-seq) remains challenging because transcriptomic cell typing, somatic variant detection and inferred copy-number approaches each have modality-specific limitations. Rare or ambiguous malignant populations are especially vulnerable to misclassification or exclusion, despite their relevance to treatment resistance, minimal residual disease, and metastasis. We developed CATFISHR, a semi-automated workflow that integrates RNA-expression similarity, inferred copy-number variation (CNV) profiles, and consensus cell typing to classify malignant cells relative to high-confidence references. CATFISHR was evaluated across eight cohorts, including seven scRNA-seq datasets spanning multiple carcinomas and melanoma subtypes, and one 10x Visium spatial transcriptomics sample. Compared with available benchmarks or ground truths, CATFISHR achieved balanced accuracy > 0.85 in six of eight cohorts and F1 score > 0.80 in six of eight cohorts. Cells uniquely identified by CATFISHR as malignant ("Hidden" cells) were present in every dataset and were not consistently explained by standard quality-control metrics. In several cohorts, Hidden cells were transcriptionally closer to benchmark malignant than non-malignant compartments; in Visium data, sampled Hidden spots contained histologist-confirmed morphologically malignant cells. CATFISHR reduces missed malignant calls while preserving rare, transitional and benchmark-discordant populations for downstream investigation.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 28 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.22.760906